Principal Investigator
Trent Wang
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20240833
Clinical Trial Summary
Single Patient IND Treatment Plan for lifileucel (LN-144) that is Out of Specification for Commercial Release
Phase
N/A
Funding Agency/Sponsor
Institutional
Disease
Cutaneous Malignancies
Contact Information
Phone Number
+1 (305) 2438376